ESC Professional Premium Access

Cellular effectiveness of drug therapies

Event: ESC Congress 2022
Topic: Drugs, Drug Targets
Session type: Moderated ePosters
Date: 28 August 2022
Time: 13:15 - 14:00

Congress Session

6 presentations in this session

Empagliflozin alleviates diabetic cardiomyopathy via inhibiting excessive autophagy and adverse remodeling in type 1 diabetic mice

Speaker: Assistant Professor R. Madonna (Pisa, IT)
Thumbnail

Effect of sacubitril/valsartan and empagliflozin on systemic inflammation and scar remodeling in a swine model of myocardial infarction

Speaker: Miss D. Martinez-Falguera (Badalona, ES)
Thumbnail

The cardioprotective effect of inhibiting SGLT1 in hyperglycemia ischemia reperfusion injury

Speaker: Miss A. Almalki (London, GB)
Thumbnail

Upregulation of SGLT1 and 2 promotes oxidative stress in right atrial appendages of patients with low-grade inflammatory responses: potential role in atrial fibrillation

Speaker: Miss W. Fakih (Strasbourg, FR)
Thumbnail

SGLT1/2 expression in the heart of transplanted patients is associated with inflammatory induction of oxidative stress: Potential protective effect of SGLT2 inhibitors

Speaker: Mr A. Mroueh (Strasbourg, FR)
Thumbnail

Evaluation of the direct protective effects of Canagliflozin on the Isoproterenol-induced cell injury in rat cardiomyocytes.

Speaker: Doctor Y. Murayama (Sagamihara, JP)
Thumbnail

6 speakers from this session

Assistant Professor Rosalinda Madonna

University of Pisa, Pisa (Italy)
5 presentations
0 follower

Miss Daina Martinez-Falguera

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)
1 presentation
0 follower

Miss Alhanoof Almalki

University College London, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Miss Walaa Fakih

University of Strasbourg, Strasbourg (France)
1 follower

Mr Ali Mroueh

University of Strasbourg, Strasbourg (France)
1 presentation
0 follower

Doctor Yusuke Murayama

Kitasato University School of Medicine, Sagamihara (Japan)
0 follower

This platform is supported by

logo Novo Nordisk